APA (7th ed.) Citation

IM, S., SA, L., S, C., AR, C., S, S., CT, L., . . . D, G. (2025). Do SGLT2 Inhibitors Improve Cardiovascular Outcomes After Acute Coronary Syndrome Regardless of Diabetes? A Systematic Review and Meta-Analysis. Medicina (Kaunas, Lithuania), 61(10), . https://doi.org/10.3390/medicina61101866

Chicago Style (17th ed.) Citation

IM, Suciu, Luca SA, Crișan S, Cozlac AR, Stoica S, Luca CT, Timar B, and Gaita D. "Do SGLT2 Inhibitors Improve Cardiovascular Outcomes After Acute Coronary Syndrome Regardless of Diabetes? A Systematic Review and Meta-Analysis." Medicina (Kaunas, Lithuania) 61, no. 10 (2025). https://doi.org/10.3390/medicina61101866.

MLA (9th ed.) Citation

IM, Suciu, et al. "Do SGLT2 Inhibitors Improve Cardiovascular Outcomes After Acute Coronary Syndrome Regardless of Diabetes? A Systematic Review and Meta-Analysis." Medicina (Kaunas, Lithuania), vol. 61, no. 10, 2025, https://doi.org/10.3390/medicina61101866.